Scientific Interchange & Workshop
This article was sponsored by PharmaEssentia.
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Breakthrough Device Designation to Natera’s Multi-Cancer Early Detection Assay
2
Targeted Approaches in Pancreatic Cancer, Chemo Intensification in CRC Take Center Stage as Key GI Oncology Presentations at ESMO 2026
3
FDA Approves Atezolizumab Plus Chemo for Stage III dMMR Colon Cancer
4
Next-Generation NAMPT Inhibitors Aim to Revive a Stalled Target in AML and MDS
5